Ipca Laboratories Ltd - Share Price Target 2026
(NSE: IPCALAB)
Sector: Healthcare
Market Cap: 3354604.02 Lakh Cr
1366.27
-1980.00
Target Price Range
1509.90
-7.10 (-0.47%)
CMP
Bullish
As on 16 Jan 2026, 03:30 pm
Market Trends
Based on 5 research reports, 6 technical indicators and 1 trade calls on SEBI Registered Telegram Channels.
Bullish8
Bearish2
Neutral2
Agg. Profit Potential10.77%
Agg. Risk 14.53%
Last updated on: 17/01/2026, 3:30 pm
Returns
| Period | Return % |
|---|---|
| 1 Month | 8.51 |
| 3 Months | 10.29 |
| 1 Year | 6.40 |
| 5 Years | 50.47 |
Last updated on: 06/09/2025, 9:30 AM
Institutional Holdings
| Institute | Percentage | No. of Shares |
|---|---|---|
| Hdfc Mutual Fund - Hdfc Mid-Cap Fund | 9.5% | 24,102,424 |
| Dsp Midcap Fund | 6.52% | 16,543,412 |
| Kotak Midcap Fund | 6.27% | 15,904,489 |
| Sbi Life Insurance Co. Ltd | 3.54% | 8,969,612 |
| Nippon Life India Trustee Ltd- A/C Nippon India Growth Mid Cap Fund | 2.21% | 5,601,979 |
| Hdfc Life Insurance Company Limited | 1.92% | 4,883,476 |
| Kotak Funds - India Midcap Fund | 1.26% | 3,200,164 |
| FLEMING FUND MANAGEMENT (LUXEMBOURG) SA | 0% | 8,000 |
Last updated on: 9/30/2025, 12:00:00 AM
Loading technical analysis...
Fundamental Data
Fundamental Analysis
P/E Ratio
47.34
P/B Ratio
4.69
PEG Ratio
2.58
ROE
9.83%
EPS
27.93
Dividend Yield
0.30%
Market Cap
3354604.02 Lakh Cr
Sector
N/A
Last Updated: 12 Nov 2025, 01:30 pm
Peer Comparison
| Company | Sentiment | Target Price | Upside |
|---|---|---|---|
About : Ipca Laboratories Ltd.
Incorporated Year
1949
City and State
Mumbai, Maharashtra
Listing Date
Director's Name
Prashant Godha
Revenue
6677.92 Cr
Net Profit
999.77 Cr